ID Flashcards
Treatment SPICE-HAM (Amp C) and ESBL (Kleb/Ecoli)
Carbapenems, Septra, Fluoroquinolones, Aminoglycoside
*Serratia, Providencia, Indole+ proteus, citrobacter, enterobacter, Hafnia, Acinetobacter, Morganella
IE “Early” Surgical Indications
Class I
- Valve dysfunction with CHF refractory to medical tx
- LS native valve IE w Staph, fungi or other resistant orgs
- Persistent fever/bacteremia > 5 days of abx
- Heart block, destructive penetrating lesion or annular/ root abscess
- IE with ICD/PPM/CRT leads in situ (require removal)
Class II
- Native valve with veggie >10mm
- Recurrent embolic events with persistent vegetation despite abx
- Minor embolic stroke/TIA without ICH with indication for surgery (delay if major ischemic/hemorrhagic stroke)
IE “Delayed” Surgical Indication
Relapsing infection of prosthetic valve (new fever/bacteremia after abx course and interval sterile BCx w/o another source)
Duke Criteria for Diagnosis IE
Definite Dx: + Veggie Cx or 2 Major or 1 Major + 3 Minor or 5 min
Possible: 1M +1m OR 3m
Major:
- Microbiologic evidence of typical IE causing organism (S aureus, Viridans, S gallolyticus/Bovis, Enteroccocus, HACEK)
- 2 cultures >12h apart OR >3 blood Cx >1h apart OR 1 cx showing coxiella burnetti OR Coxiella antiphase 1 IgG >1:800
- Echo evidence of endocardial involvement (new valve regurg, oscillating mass, abscess, prosth valve dehiscence)
Minor:
- Fever >38C
- Blood cultures positive but not meeting major crit
- Predisposing Dz (IVDU, prosthetic valve, heart defect)
- Immune: +RF, GN, Osler nodes, Roth
- Vascular: Stroke/TIA, septic infarcts (pulm, renal, hepatic, splenic), mycotic aneurysm, ICH, conjunctival hemorrhage, Janeway lesions
Treatment for Prosthetic Valve/Lead associated IE
Add Rifampin and Gentamicin to regimen x6 weeks
IE Prophylaxis: Indications
- Appropriate underlying condition:
- Past IE
- Any prosthetic heart valve (incl TAVI, LVAD, rings/clips; NOT PPM/ICD/stents)
- Unrepaired congenital heart disease or repaired within 6 mo or with residual defect (NOT for septal defects w/ complete closure)
- Cardiac transplant patients who develop valvulopathy
PLUS
- Appropriate procedure:
- Dental procedure with gingival manipulation
- Respiratory tract procedure (or bronch if bx planned)
NOT FOR GI/GU procedures
IE PPX: What to use?
Amox 2g PO x1 , Or single dose Amp/ Keflex/ Doxy/ Azithro/ Ancef / CTX
Empiric Treatment of Cystitis
1st line: Nitrofurantoin x5 days (avoid if concern for pyelo), Septra x3 days (avoid in preg), or Fosfomycin x1 (useful for ESBL, avoid if pyelo)
2nd line: B-lactam or FQ
Empiric Treatment of Pyelonephritis
IV Beta-lactam (preferred in preg) x7-14d or FQ x5-7d
Indications to treat asymptomatic bacteruria
and duration
1) Pregnant - treat x4-7 days
2) Invasive urologic procedure - tx 1-2 days
Treatment Gonorrhea
Ceftriaxone 500 mg IV x1 + Doxy 100mg BID x7d (Chlam Co-Tx) **no doxy in T2/T3 of preg
*Pen all: Azithro + Gent/Cipro or Gent+Doxy
Test of cure for all GC infxn
Treatment DGI
CTX 1g IV/IM Q24 hrs x 7 days min
Two clinical syndromes of disseminated gonococcal infection
1) Tenosynovitis, Dermatitis (pustules), Arthralgias
2) Septic arthritis (typ monoarthritis)
Treatment Chlamydia
Doxy 100mg PO BID x7d (or azithro 1 g PO x1)
Test of cure only needed if ongoing sx, suboptimal compliance, alternative regimen, or pregnant
Clinical Features of Lymphogranuloma venereum (LGV) from Chlamydial Infection
Bloody bowel movements
Painful and purulent lymphadenopathy
Proctitis with crypt abscesses, granulomas and giant cells on biopsy
Treatment of LGV
Doxycycline x 21 days and treat partners with Azithro
Stages of Syphillis
Primary (w/in 3 wks): Painless chancre, regional LN
Secondary (w/in 6 months): Fever, rash, alopecia, meningitis, uveitis, hepatitis, LN, arthralgias, condylomata lata
Latent Early (<1 yr) or Late (>1yr): + Serology, no Sx.
Tertiary: Cardiac (Aortitis), MSK (Gummatous arthritis), Late neurosyphillis (tabes dorsalis, paresis, argyle pupil)
Screening/Diagnostic Tests for Syphillis
Screening: VDRL or RPR (ie. non-treponemal tests)
If + –> Diagnostic test (= treponemal tests)
- enzyme immunoassay (EIA)
- darkfield microscopy
- Fluorescent treponemal Ab absorption (FTA-ABS)
- Treponema pallidum particle agglutination assay (TPPA)
Either +RPR or +TPPA w/ +screen = recent/prior infxn
+RPR and -TPPA = inconclusive (FP vs early vs old treated or untreated)
Treatment of Syphillis
Primary, Secondary, Early Latent: PenG 2.4 MU IM x1
Late Latent (>1y since acquisition)/Tertiary: PenG 2.4 mU IM qweekly x3*
Neurosyphillis: Aq Penicillin 4mU Q4hrs IV x14 days –> Pen G 2.4MU IM x1 if possible late latent *
*for PCN allergy: desensitize if late latent/tertiary, neurosyphilis, or preg
SSTI Association: Salt Water
And Tx
Vibrio (Doxy + ceftaz)
SSTI Association: Fresh Water
Aeromonas (doxy + ceftaz)
SSTI Association: DM
Polymicrobial, pseudomonas
SSTI Association: Colon CA
Clostridium (PCN + clinda)
SSTI Association: Bites - bugs and tx
*when to do tetanus
Human: Eikenella, strep/s aureus, anaerobes
Animal: Pasturella, capnocytophaga canimorsus, staph/strep, anaerobes
All treated w/ amox-clav OR 2nd/3rd gen ceph + flagyll, or moxi, or doxy + clinda
Minor wound: Tetanus if >10y since booster and completed series or unknown/incomplete series (immigrant),
All other wounds: >5y since booster and completed series. Unknown gets vaccine + TIg
Treatment Purulent skin and soft tissue infection eg folliculitis (hair follicle), furuncle (follicle into dermis/SC), carbuncle (several follicles), abscess (pus in dermis/SC)
1) I&D - all
2) +/- empiric ABX
- Mild: None
- Moderate (systemic signs of infxn): Keflex (if low MRSA prev), Septra, Doxy
- Severe (immunocomp, systemic signs infxn, failed prior abx/I&D): Vanco for MRSA, Ancef for MSSA
Treatment non-purulent skin and soft tissue infections eg Impetigo (S aureus), Erysipelas (GAS; epidermis and dermis), Cellulitis (GAS; epidermis, dermis, SC), Nec Fasc
Treat predisposing trauma, tinea pedis, xerosis, lymphedema
Mild (no purulence or signs systemic infxn): Keflex x 5 days
Moderate (fever but VSS): Ancef –>Keflex x5-7d
Severe (abn VS, unstable) - see nec fasc
*Cover MRSA if penetrating trauma, IVDU, hx MRSA
Treatment necrotizing fasciitis (erythema, systemic tox, gangrene, induration, hemorrhagic bullae, pain out of proportion)
1) Urgent surgical consult - immediate OR
2) Empiric ABX: Pip-tazo + Clinda + Vanco +/- IVIG if shock or pre-op
4) Post-op once recovering, narrow based on cultures
Categories necrotizing fasciitis
Type 1 = GAS (pyogenes) –> hemorrhagic bullae, elevated CK, younger, minor trauma –> definitive tx. = Pen + Clinda
Type 2 = Polymicrobial –> DM, gas/crepitus, older, pelvic wounds –> Tazo + Vanco or carbapenem
Indications for ABX Prophylaxis for skin and soft tissue infection
> =3 episodes cellulitis/year despite managing rf (revascularization, wound care, footwear, compression, tinea)
Diagnosis: Streptococcal Toxic Shock Syndrome
- Hypotension (sBP<90) +
- Isolation of GAS from sterile site +
- 2 of: AKI (Cr>177), Coagulopathy (plt <100, DIC), AST/ALT/bili >2x ULN, ARDS, generalized rash
Treatment: Toxic Shock Syndrome
and chemoppx
Droplet/Contact precautions
Surgical debridement +/- IVIG if severe infxn
Beta Lactam + Clindamycin, IVF
Chemoprophylaxis: Keflex x10d (clinda if allergy)
*Hyperbaric O2 efficacy UNKNOWN
Black eschar in nose of a diabetic or along palatal mucsa
Mucormycosis (Rhizopus sp)
Tx with ampho B
Otitis externa in diabetic
Pseudomonas
Treat with ciprodex
Empiric treatment of osteomyelitis and PJI
*MC bugs
Hold ABX until bone bx or aspirate obtained
Then CTX 2g IV Q24h + Vancomycin pending Cx
Duration = 4-6 weeks or high dose oral
Surgery for PJI
MC: S Aureus; DM (strep, GNB, anaerobes), IC (candida, myco, aspergillus)
Septic Arthritis Empiric Treatment
CTX 2g IV Q24hrs + Vancomycin (if MRSA RFs)
COVID-19: Risk factors for severe infection
Male
Non-white (black, hispanic)
Older age
Pre-existing: DM, CVD, HTN, lung dz, obesity, Ca, IC
COVID-19: Markers of prognostic significance
High D-dimer, LDH, CRP, Ferritin, troponin/CK, LFTs
Low lymphocyte count
COVID-19: Treatment
- No O2 requirements: Supportive Care
- Needing O2/MV/admitted: Dex 6 IV/PO x 10 days
- Needing O2 NOT intubated: Remdesivir 200mg IV x1 then 100mg IV x4d
- Needing O2/MV + systemic inflammation (CRP>75) and worsening despite 24-48h steroids: Tocilizumab (mort benefit)
- VTE prevention
- Baricitinib (JAKi) for mod COVID (req O2 by NP) and criticially ill (O2 by HFNC, NIV, MV, ECMO) decreases mort and progression to MV
- Do not start abx empirically
- Colchicine, IFN, vit D, plaquenil, ivermectin, lopinavir or ritonavir NOT recommended
- In mild outpatient unvaccinated: sotrovimab, remdesevir, molnupiravir
COVID-19: Isolation
Droplet Contact minimum 10 days from symptom onset + symptom improvement demonstrated
Avoid nebulized meds (increased airborne spread)
10 days isolation at home
14d isolation in hospital unless IC or severe illness then 21d bc prolonged shedding
All household contacts - isolation x14 days
Manifestations Lyme Disease
Early: Erythema Migrans = clinical dx, no need for serology
Early/Late:
- CNS: Meningoencephalitis, CN palsies, encephalopathy (late), peripheral neuropathy (late)
- Cardiac: Heart block, myopericarditis
Late: Arthritis (oligoarthritis most common)
Treatment Lyme Disease
Doxycycline 100 BID for most
- x 10 days for erythema migrans
- x14-21 days for all other manifestations, 28d for arthritis
CTX 1g IV Q24hrs x14-21d for CNS or cardiac lyme or treatment failure for lyme arthritis with objective severe synovitis
*DMARD/biologic if post-abx lyme arthritis
- no additional abx without objective evidence of reinfection
- consider coinfection (babesia/anaplasma) if fevers on abx
When to obtain CT Head prior to LP for meningitis?
Immunocompromised
Signs of elevated ICP: papilledema, new sezures, altered mental status, FND
CSF parameters in bacterial meningitis
WBC >1000, neutrophilic (not always in early presenters)
Low glucose (<1.9 = 99% Sn)
High protein (>2.2 = 99% Sn)
*Biochem/Cell count minimally affected by ABX w/i 48hr
CSF parameters in viral meningitis
WBC <1000, lymphocytic
Glucose normal
Protein normal/high
CSF parameters in TB/Fungal meningitis
WBC variable, lymphocytic
Glucose low
Protein high
Bacterial Meningitis: Empiric Treatment
1) Dexamethasone 10mg IV Q6hrs x4d before/with 1st ABX (stop if CSF nonturbid, low cell count, OR non-pneumococcal by Cx)
2) ABX: CTX 2g IV Q12hrs, Vanco 1g IV Q8 hrs, +/- Ampicillin 2g IV Q4hrs (if age >=50 or immunocomp for listeria)
* Pen allergic: Vanco + Moxi + Septra OR Mero + Vanco
Bacterial meningitis: Duration of treatment
Strep pneumo (GP diplococci): 10-14 days
Neisseria (GN diplococci): 7 days
Listeria (GPB): 21 days
Indications for chemoprophylaxis for contacts of person with acute bacterial meningitis from Neisseria
-and what drug
Household contacts, sharing sleeping quarters, exposed to oral/nasal
HCW with close unprotected contact
Daycare contacts
Airline passenger beside patient (not aisle) if >8 hr flight
Ceftriaxone 250 g IM x1 or Cipro 500 mg PO x1 or Rifampin 600 mg PO BID x 2d
WITHIN 10 days
What to give for meningitis chemoprophylaxis
Ceftriaxone 250 g IM x1 or Cipro 500 mg PO x1 or Rifampin 600 mg PO BID x 2d
WITHIN 10 days
Indications for IMMUNOppx (vaccine) for contacts of person with acute bacterial meningitis from Neisseria
-and what tx
Contacts with patient with invasive meningococcal disease (IMD):
Household contacts with shared sleeping quarters or nasal/oral contam
Daycare contacts
Tx: Men-C-ACYW or 4CMenB can be considered
Empiric Pneumonia Treatment: Healthy Outpatients
Amoxicillin 1g PO TID x5-7 days or
Doxy 100 mg PO BID x5-7 days or
Azithro 500 mg x1 –> 250 OD x 5days
Empiric Pneumonia Treatment: Outpatients with comorbidities (chronic heart, lung, liver, renal, diabetes, EtOH, Ca, asplenia)
Amox-Clav 875/125 BID + Azithro 500->250 x5-7 days
Resp FQ (Moxi, Levo)
Empiric pneumonia treatment: Inpatients
Non-ICU: (Beta-lactam + Macrolide) OR Resp FQ
ICU: (beta-lactam + macrolide) OR (beta-lactam +resp FQ)
Aspiration: NO empiric anaerobic coverage unless empyema/abscess
–> PO if afebrile x48 and <=1 of: HR>100, RR>24, SBP<90, paO2<90%, AMS, can take PO)
*Add vanco or linezolid if MRSA RFs
*Use ceftaz/cefepime/tazo as beta-lactam if psedo RFs
eg beta lactam: CTX, cefotaxime, ceftaroline, amp-sulbactam
MC HAP/VAP bugs and Empiric Treatment
*S Pneumo, H Influenza, MSSA, Pseudomonas
7days of:
1. Piptazo or cefepime or imi/meropenem or levoflox +/-
2. vanco or linezolid (if MRSA risks) +/-
3. Addnl anti-pseudomonal agent (ceftaz or AG or colistin or addnl agent from #1) if RFs for resistant pseudomonas
Indications to treat bloody diarrhea empirically
- Suspicion for C.diff
- Immunocompromised + sick +/- dysentry (freq bloody BM, abdo pain, tenesmus, fever)
- Recent travel with T>=38.5 or S&S sepsis
Antimicrobials for travelers diarrhea
C- Cipro for Central/South america
A- Azithro for Asia
Indications to send stool O&P
> =14 day duration
Travel
Immunocompromised
*increased yield if ordered dailyx3d
Definition severe C.diff
WBC >=15 or Cr >1.5x baseline
RF for severe illness: Age >65, T>38, IC, Alb <30